COVAXIN potentially effective against three key variants of SARS-CoV-2

COVAXIN-vaccinated sera effectively neutralised several SARS-CoV-2 variants (B.1.617(India, double mutant), B.1.1.7(UK), B.1.1.28(Brazil P2) & heterologous strain) in an in-vitro plaque reduction neutralisation assay suggesting COVAXIN may be effective against multiple variants

Biospace Inc.